Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
InterDigital
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
5G And 6G Trends Will Fuel IP Expansion Despite Challenges
Key Takeaways Successful licensing negotiations and a shift to recurring, high-margin cash flows are expected to drive sustained earnings and margin improvements. Strong positioning in wireless standards and IP, alongside global expansion, supports scalable, diversified revenues and stable long-term royalty streams.
View narrative
US$311.00
FV
14.4% undervalued
intrinsic discount
-6.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Sylvamo
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Eco-Friendly Trends Will Expand Global Specialty Paper Markets
Key Takeaways Operational upgrades and tight supply position Sylvamo for outsized earnings, margin gains, and strong pricing power beyond analyst expectations. Leadership in sustainable products and financial flexibility enable aggressive growth, buybacks, and strategic investments, supporting long-term industry outperformance.
View narrative
US$68.00
FV
34.4% undervalued
intrinsic discount
0.0086%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
GMS
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Urban Growth And Green Standards Will Fuel Construction Renewal
Key Takeaways Accelerated cost savings, digital investments, and scalable infrastructure are enhancing efficiency and positioning GMS for strong margin expansion and leading free cash flow conversion. Strategic focus on premium products, green building demand, and partnerships with national builders positions GMS to capture market share and deliver above-average long-term growth.
View narrative
US$110.00
FV
0.09% undervalued
intrinsic discount
1.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Lam Research
AN
AnalystLowTarget
Consensus Narrative from 30 Analysts
China Exposure And Export Limits Will Compress Semiconductor Margins
Key Takeaways Export controls and rising local competition threaten revenue growth and pricing power, especially given Lam's heavy reliance on the Chinese market. High R&D demands and tightening sustainability regulations are likely to compress margins and increase ongoing compliance and operating expenses.
View narrative
US$81.52
FV
22.8% overvalued
intrinsic discount
4.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
Lockheed Martin
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Supply Chain Issues And Shifting Budgets Will Constrain Defense Programs
Key Takeaways Heavy dependence on major defense programs increases risk from shifting geopolitical budgets and evolving defense priorities. Lagging investment in emerging defense technologies and rising ESG pressures threaten long-term competitiveness and earnings growth.
View narrative
US$398.00
FV
12.1% overvalued
intrinsic discount
3.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Innovative Industrial Properties
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Increasing Cannabis Legalization Will Drive Robust Gains Despite Risks
Key Takeaways Accelerated tenant recovery, regulatory tailwinds, and sector diversification position the company for rapid revenue rebound and future earnings growth. Shifting capital trends and expanding healthcare adoption support premium valuations, stable margins, and durable long-term dividend growth.
View narrative
US$90.00
FV
39.0% undervalued
intrinsic discount
-3.36%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Elevance Health
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
ACA And Medicaid Will Squeeze Margins Though Tech Will Aid
Key Takeaways Elevated costs in government-backed plans and greater reliance on value-based care could compress margins despite operational improvements and diversification strategies. Increasing regulatory changes, political uncertainty, and provider sophistication in technology may erode pricing power and add to earnings volatility.
View narrative
US$297.00
FV
6.6% overvalued
intrinsic discount
6.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
UnitedHealth Group
AN
AnalystLowTarget
Consensus Narrative from 23 Analysts
Medicare Scrutiny Will Deepen Margin Compression In Managed Care
Key Takeaways Government scrutiny, regulatory interventions, and policy headwinds are likely to reduce margins and profitability across UnitedHealth's core business segments. Rising medical costs, intensifying competition, and operational challenges threaten revenue growth, expose structural weaknesses, and endanger long-term earnings potential.
View narrative
US$198.00
FV
55.3% overvalued
intrinsic discount
3.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
3 days ago
author updated this narrative
Oracle
AN
AnalystLowTarget
Consensus Narrative from 33 Analysts
Legacy Model Will Falter Amid Rising Compliance And Cloud Competition
Key Takeaways Reliance on legacy platforms and shifting customer preferences threaten core revenue streams, gross margins, and create heightened long-term volatility for future income. Intensifying competition and regulatory demands will increase compliance costs and further diminish Oracle's pricing power, scalability, and overall growth potential.
View narrative
US$175.00
FV
35.1% overvalued
intrinsic discount
15.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies